News18» News»India»Shilpa Medicare Can Make 100-200 Million Doses of Covid-19 Shot, Says Executive; Shares Jump 9.2%
1-MIN READ

Shilpa Medicare Can Make 100-200 Million Doses of Covid-19 Shot, Says Executive; Shares Jump 9.2%

Shilpa Medicare Ltd (Image credits: Moneycontrol)

Shilpa Medicare Ltd (Image credits: Moneycontrol)

Shilpa Medicare Ltd’s shares jumped as much as 9.2% on India’s National Stock Exchange following the news.

Drugmaker Shilpa Medicare Ltd has the production capacity to make 100-200 million doses of a recombinant vaccine for COVID-19, a company executive told Reuters on Wednesday.

The company’s shares jumped as much as 9.2% on India’s National Stock Exchange following the news.

Read all the Latest News and Breaking News here

first published:April 07, 2021, 14:02 IST